Durvalumab

Durvalumab Suppliers list
Company Name: TargetMol Chemicals Inc.
Tel: +1-781-999-5354 +1-00000000000
Email: marketing@targetmol.com
Products Intro: Product Name:Durvalumab;MEDI 4736
CAS:1428935-60-7
Purity:98.00% Package:1 mg;25 mg;5 mg;50 mg Remarks:REAGENT;FOR LABORATORY USE ONLY
Company Name: LEAPCHEM CO., LTD.
Tel: +86-852-30606658
Email: market18@leapchem.com
Products Intro: Product Name:Durvalumab
CAS:1428935-60-7
Purity:0 Package:1g; 5g; 25g; 1kg; 5kg; 25kg Remarks:0
Company Name: SPIRO PHARMA  
Tel:
Email: eric_feng1954@126.com
Products Intro: Product Name:Durvalumab
CAS:1428935-60-7
Purity:99
Company Name: Shanghai EFE Biological Technology Co., Ltd.  
Tel: 021-65675885 18964387627
Email: info@efebio.com
Products Intro: Product Name:Durvalumab
CAS:1428935-60-7
Purity:95% Package:2mg;5mg;10mg
Company Name: ShangHai Biochempartner Co.,Ltd  
Tel: 17754423994 17754423994
Email: 2853530910@QQ.com
Products Intro: Product Name:Durvalumab
CAS:1428935-60-7
Purity:95% Package:100ug;500ug;1mg
Durvalumab Basic information
Product Name:Durvalumab
Synonyms:Durvalumab;MEDI4736;Research Grade Durvalumab(DHJ70102)
CAS:1428935-60-7
MF:
MW:0
EINECS:
Product Categories:
Mol File:Mol File
Durvalumab Structure
Durvalumab Chemical Properties
storage temp. Store at 4°C, do not freeze
solubility Soluble in DMSO
form Liquid
color Colorless to light yellow
Safety Information
MSDS Information
Durvalumab Usage And Synthesis
UsesDurvalumab is used to treat non-small cell lung cancer (NSCLC) that spread to nearby tissues and cannot be removed by surgery but has not worsened after being treated with other chemotherapy medications and radiation treatments. Durvalumab injection is also used in combination with etoposide (Etopophos) and either carboplatin or cisplatin to treat extensive-stage small cell lung cancer (ES-SCLC) in adults whose cancer has spread throughout the lungs and to other parts of the body.
Side effectsswelling of your arms or legs;constipation;hair loss
Durvalumab Preparation Products And Raw materials
Tag:Durvalumab(1428935-60-7) Related Product Information
Follicle stimulating hormone Secukinumab Daratumumab OMALIZUMAB Dulaglutide Trastuzumab emtansine Ranibizumab palivizumab Immunoglobulin G4,anti-(human integrin R4) (human-mouse monoclonal AN100226 c4-chain),disulfide with human-mouse monoclonal AN100226 light chain,dimer Eculizumab Matuzumab ticilimumab tremelimumab CNTO 148 Aflibercept abciximab Avelumab nimotuzumab belimumab